North Korea’s fight against tuberculosis gets a boostBMJ 2010; 340 doi: https://doi.org/10.1136/bmj.c2223 (Published 22 April 2010) Cite this as: BMJ 2010;340:c2223
- Jane Parry
- 1Hong Kong
A team of tuberculosis (TB) experts will travel to North Korea later this month to put the finishing touches to the country’s first laboratory with the capability to diagnose drug resistant TB. At the same time the country is in the final stages of negotiations with the Global Fund to Fight AIDS, Tuberculosis and Malaria for a $23m (£14.9m, €17m) grant for TB control.
With an estimated incidence rate of 340 per 100 000, North Korea is considered a country with a high TB burden, but it relies entirely on outside aid for TB control. It has been unable to diagnose drug resistant cases and conduct drug …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial